Understanding the Global Catheters Market: Trends and Developments

 Introduction:

The catheters market refers to the global market for medical devices that are inserted into the body for various purposes, such as the delivery of fluids, drugs, or contrast agents, as well as for diagnostic and therapeutic interventions. Catheters are thin, flexible tubes that can be inserted into different parts of the body, including blood vessels, the urinary tract, the digestive system, and the respiratory system.

Global Catheters market Overview

The global catheters market is projected to reach USD 24.2 billion by 2025 from USD 15.9 billion in 2020, at a CAGR of 8.7%. 

The growing target patient population and the rising focus on minimally invasive surgical procedures over conventional surgery are the major factors driving the growth of catheters market.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6247803

Market Segmentation: -

On the basis of type, the global catheters market is segmented broadly into cardiovascular, urological, intravenous, neurovascular, and specialty catheters. Cardiovascular catheters commanded the largest share of the catheters market in 2019 and are expected to grow at the highest CAGR during the forecast period. This is primarily attributed to factors such as the high incidence of CVD, the growing geriatric population, and increasing awareness regarding early diagnosis. These factors have resulted in an increase in cardiovascular surgeries, which positively impacts the cardiovascular catheters market.

Based on end user, the catheters market is segmented into hospitals, long-term care facilities, diagnostic imaging centers, and other end users. In 2019, hospitals were the largest end users of catheters. This segment is expected to grow at the highest CAGR, majorly due to the high volume of target procedures performed in hospitals. The presence of big cath labs and electrophysiology labs in hospitals and a growing patient population are other key drivers of this market. The emergence of advanced diagnostic imaging catheters, coupled with the demand for minimally invasive procedures, is accelerating the adoption of catheters in hospitals.

Regional Analysis:

The catheters market has been divided into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global catheters market in 2019. This is attributed to various factors such as the large number of target procedures performed in the region, the presence of a well-established healthcare system, and investments by hospitals to upgrade & expand operating capabilities.

Recent Development:

·         In 2019, Boston Scientific Corporation acquired BTG plc. (UK). This acquisition expanded Boston Scientific’s product offerings for minimally invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.

·         In 2019, Medtronic launched Telescope Guide Extension Catheter.

·         In 2018, Becton, Dickinson and Company (BD) acquired TVA Medical, Inc. (US). The acquisition strengthened BD’s product portfolio with the addition of dialysis catheters, drug-coated balloons, standard angioplasty balloons, and endovascular stent graft products from TVA Medical.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=6247803

Top Key Players:

The prominent players operating in this market include Medtronic (Ireland), Edwards Lifesciences Corporation (US), Teleflex Incorporated (US), Abbott (US), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), ConvaTec Group (UK), Coloplast (Denmark), Johnson & Johnson Services (US), Terumo Corporation (Japan), Hollister Incorporated (US), Stryker (US), Cook Medical (US), and Merit Medical Systems (US).

Conclusion

In conclusion, the global catheters market is expected to continue growing in the coming years due to the increasing prevalence of chronic diseases and the growing demand for minimally invasive procedures. Advancements in catheter design and materials are also expected to contribute to market growth. However, the market faces challenges such as the risk of infection and regulatory hurdles. Overall, the catheters market is a dynamic and evolving field, with new technologies and applications being developed to address the needs of patients and healthcare providers.

 

Revolutionizing Blood Testing: The Growth of Blood Screening Market

 Introduction to the Blood Screening Market

The blood screening market is an important segment of the healthcare industry. It is used to diagnose and monitor a wide range of medical conditions, including infectious diseases, genetic disorders, and other conditions. The market is highly regulated, with a variety of regulatory bodies and standards that must be followed. The market is also highly competitive, with a variety of companies competing for a share of the market. This growth is attributed to the increasing demand for blood-based diagnostics, the high prevalence of infectious diseases, and the growing need for personalized medical care.

Global Blood Screening Market Overview

The global Blood screening market in terms of revenue was estimated to be worth $2.5 billion in 2021 and is poised to reach $3.8 billion by 2026, growing at a CAGR of 8.4% from 2021 to 2026.

The global blood screening market is expected to grow at an impressive rate during the forecast period. The global blood screening market is driven by the increasing prevalence of infectious diseases and genetic disorders, rising demand for effective diagnosis and treatment of diseases, increasing awareness regarding early diagnosis of diseases, and advancements in technology. The growing number of collaborations among universities, research institutes, and pharmaceutical companies is also expected to fuel the growth of the market.

Market Segmentation

The global blood screening market is segmented based on technology, application, end user, and region. By technology, the market is classified into nucleic acid testing, enzyme-linked immunosorbent assay (ELISA), western blotting (WB), flow cytometry, immunohematology, and other technologies. By application, the market is divided into infectious diseases, genetic disorders, and other applications. By end user, the market is segregated into hospitals.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042

Drivers of the Blood Screening Market

·         Increasing prevalence of blood-related diseases: The prevalence of blood-related diseases such as HIV, hepatitis, and syphilis is increasing globally, which is driving the need for blood screening.

·         Need for accurate and reliable results: The demand for accurate and reliable results from blood screening tests is increasing, due to the need to detect diseases at an early stage.

·         Rising awareness of blood safety and donor screening: The rising awareness of the importance of blood safety and donor screening has led to an increase in the use of blood screening tests.

·         Growing demand for blood transfusions: The growing demand for blood transfusions is driving the need for blood screening tests to ensure the safety of transfusions.

·         Technological advancements in blood screening: Technological advancements in the field of blood screening are enabling the development of more accurate and efficient tests.

·         Government initiatives for enhancing blood safety: Governments around the world are taking initiatives to promote blood safety and donor screening, which is driving the growth of the blood screening market.

Challenges Faced by the Blood Screening Market

·         Regulatory Challenges: Blood screening tests are subject to stringent regulatory requirements, which can be difficult to meet. This can lead to delays in the market entry of new products or technologies and can limit the number of suppliers in the market.

·         Cost of Testing: Blood screening tests can be expensive, and the cost of testing can be a barrier to access for some patients.

·         Technological Limitations: Blood screening tests can be limited by the technology available. New technologies such as next-generation sequencing are still relatively expensive and not widely available.

·         Quality Control: Quality control is an important factor in the accuracy of blood screening tests. Poor quality control can lead to incorrect results and potentially dangerous outcomes for patients.

·         Accessibility: Accessibility to blood screening tests is limited in some areas due to lack of availability or affordability. This can lead to delays in diagnosis and treatment.

Regional Blood Screening Market Analysis

The global blood screening market is segmented into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest share of the global market. The growth of the North American market can be attributed to the increasing healthcare spending, the increasing prevalence of chronic disorders, and the highly developed healthcare systems in the US and Canada.

Major Players in the Blood Screening Market

Prominent players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Grifols (Spain), Abbott Laboratories, Inc. (US), bioMérieux (France), Bio-Rad Laboratories, Inc. (US) among others.

 

Recent Developments and Trends in the Blood Screening Market

• In May 2021, Beckmann Coulter (US) launched SARS-CoV-2 IgG.
• In September 2021, Roche Diagnostics (Switzerland) acquired TIB Molbiol Group (Germany). This acquisition will enhance Roche’s broad portfolio of molecular diagnostics solutions with a wide range of assays for infectious diseases, such as identifying SARS-CoV-2 variants.
• In February 2020, BD (US) acquired NAT Diagnostics (US), this acquisition strengthened an early-stage company developing a molecular diagnostic platform for POC testing.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=267747042

Conclusion:

The Blood Screening Market is expected to witness significant growth in the coming years due to the increasing prevalence of infectious diseases, technological advancements, and the growing demand for blood tests. The market is driven by rising awareness about the importance of blood screening, increasing demand for safer and more accurate blood products, and the development of innovative products. Additionally, the emergence of mobile blood screening technology, government initiatives, and the growing number of blood testing services and centers are expected to drive market growth.

The Future of ERCP Market: Predictions and Insights for the Next Five Years

 Introduction

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a minimally invasive procedure used to diagnose and treat diseases of the bile and pancreatic ducts. It is used to diagnose conditions such as bile duct stones, biliary strictures, and pancreatic cancer. The procedure involves the insertion of an endoscope into the patient’s mouth and then into the duodenum. A small catheter is then passed through the endoscope and into the common bile duct or pancreatic duct. Dye is injected through the catheter and x-rays are taken to help diagnose the condition.

Global ERCP Market Overview

The global ERCP market in terms of revenue was estimated to be worth $1.3 billion in 2021 and is poised to reach $2.0 billion by 2026, growing at a CAGR of 9.6% from 2021 to 2026.

Endoscopic retrograde cholangiopancreatography (ERCP) is a medical process that involves the insertion of a thin, flexible tube that is fitted with a camera through the mouth and esophagus, and into the duodenum. The procedure is used to diagnose and treat diseases related to the gallbladder, bile ducts, and pancreas. This medical procedure is used to diagnose and treat a variety of conditions, including pancreatic cancer, bile duct cancer, pancreatitis, and gallstones.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170242954

Drivers of the ERCP Market

Nowadays, the global incidence of cancer is increasing. According to the WHO, cancer is the second-leading cause of death globally and was responsible for 9.6 million deaths in 2018. According to the American Cancer Society's estimates, about 41,260 new cases of liver cancer and intrahepatic bile duct cancer will be diagnosed in the US in 2022. Liver cancer incidence rates have more than tripled since 1980, while death rates have more than doubled during this time. In 2021, around 60,430 new pancreatic cancer cases will be diagnosed in the US. Every year in the United Kingdom (2016–2018), approximately 10,500 new pancreatic cancer cases and 6,200 new liver cancer cases were diagnosed. Globally, 458,918 new cases of pancreatic cancer were reported in 2018, and 355,317 new cases are estimated to occur until 2040 (GLOBOCAN 2018 estimates). Since ERCP is often used as a diagnostic tool in hepatic, biliary, and pancreatic cancers, the rising incidence of these cancers is directly related to the impact on the ERCP market.

Opportunities of ERCP Market

Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies globally. According to the World Economic Forum, the emerging economies will account for around one-third of global healthcare expenditure in 2021. More than half of the world's population resides in India and China, owing to which these countries are home to the highest number of patients.

The increasing burden of cancer, rapid improvements in healthcare infrastructure, the rapid growth of medical tourism, and the presence of flexible regulation in these countries encourage players in the endoscopy equipment market to expand their presence in emerging countries.

Several endoscopy equipment manufacturers are currently setting up their facilities in Asia, the Middle East, and Latin America. Karlstrom, for example, has already established manufacturing and R&D facilities in these countries. In addition, market saturation in developed regions, such as North America and Europe, will force manufacturers to focus on emerging markets in the coming years.

Regional ERCP Market Analysis

Governments in several Latin American countries focus on improving their respective healthcare systems, and the healthcare sector in Brazil has undergone significant changes, making the country one of the world's most promising and attractive markets. Along with this, Japan's well-developed healthcare system with universal health insurance coverage and the focus of countries such as China and India on healthcare infrastructure improvements to serve large populations of patients with critical illnesses, including cancer and tumors, are driving the market in these regions forward at a rapid pace.

Major Players in the ERCP Market

The major players in the global ERCP market include Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B. Braun Melsungen AG (Germany).

Recent Developments in ERCP Market

• In January 2022, Cook Medical (US) launched an endoscopic clipping device, namely Instinct Plus, which is compatible through a duodenoscope, has applications for defect closure, anchoring procedures and prophylactic clipping in the gastrointestinal (GI) tract.
• In May 2021, STERIS PLC (US) acquired Cantel Medical (US) which enabled STERIS Healthcare to expand its product portfolio and cater to customers worldwide. 
• In March 2021, Fujifilm Holdings Corporation (Japan) acquired Hitachi, Ltd.’s Diagnostic Imaging-related Business (Japan), adding to the former’s stronghold in the healthcare business.
• In October 2020, Olympus Corporation (Japan) launched two endotherapy devices, StoneMasterV and VorticCatchV, to increase the efficiency in bile duct stone management and retrieval for ERCP announced a partnership with Holberg to develop and distribute the Autoscore algorithm.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=170242954

Conclusion:

Endoscopic Retrograde Cholangiopancreatography (ERCP) is an important diagnostic and therapeutic tool for the diagnosis and management of pancreatic and biliary diseases. This growth is attributed to the rising prevalence of gastrointestinal diseases, growing geriatric population, and rising demand for minimally invasive procedures.

In addition, the increasing prevalence of gallstones, rising awareness regarding ERCP procedures, and technological advancements in the ERCP systems are further expected to boost the growth of the market. However, the high cost of the procedure and the lack of skilled professionals are expected to impede the growth of the market.

The Future of Drug Delivery: An Insight into the Wearable Injectors Market

 Introduction

Wearable injectors are medical devices used to deliver drugs and other therapeutic agents through skin or mucosal membranes. The growth of the wearable injectors market is driven by factors such as the rising prevalence of chronic diseases, increasing focus on patient adherence and convenience, and technological advancements in drug delivery devices. However, the high cost of wearable injectors may restrain the growth of the market to a certain extent.

Global Wearable Injectors Market Overview

The global Wearable injectors market is projected to reach USD 11.6 billion by 2026 from USD 7.3 billion in 2021, at a CAGR of 9.9% during the forecast period.

The global wearable injectors market is expected to grow at a significant CAGR during the forecast period. Wearable injectors are advanced medical devices that are used to deliver drugs and vaccines into the body of a patient in an efficient and precise manner. They are designed to provide comfort and convenience to the user and ensure accurate dosage of drugs. Growing prevalence of chronic diseases, technological advancements in drug delivery devices, increasing adoption of self-administration of drugs, and rising demand for home healthcare are the major factors driving the growth of the global wearable injectors market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004

Market Segmentation:

By type, the global market is segmented into on-body injectors and off-body injectors. The on-body injectors segment accounted for the largest share in the forecast year. The large share of this segment can be attributed to the patients ease to deliver a precise amount of drug to the body over a controlled period of time.

Based on technology, the wearable injectors market is segmented into spring-based, motor-driven, rotary pump, expanding battery, and other technologies. The spring-based technology segment accounted for the largest share in the forecast period. The large share of this segment can be attributed to the rising demand for adhesive patches, as these devices are user-friendly and enable patients to accurately deliver the required drug subcutaneously.

Based on therapy, the wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (such as Parkinson's disease, thalassemia, and primary immunodeficiency disorders). The diabetes segment accounted for the largest share in the forecast period. The large share of this segment can be attributed to The high burden of diabetes across the globe, coupled with the growing availability of wearable injectors for the treatment of these diseases, is driving the growth of this market segment.

Based on end user, the market is segmented into hospitals and clinics and home healthcare settings. The hospitals and clinics segment accounted for a larger market share during the forecast period. The large share of this segment can primarily be attributed to the rising preference for the self-administration of medication and the increasing need to curb healthcare costs. In addition, the growing demand for technologically developed drug delivery approaches, which lower the hospitalization rate and require minimal expertise, is expected to boost the growth of the home healthcare settings segment.

Regional Analysis: -

The wearable injector market in North America accounted for the largest market during the forecast period. The large share of North America in this market is to the rising prevalence of chronic and lifestyle-related diseases and the presence of advanced healthcare infrastructure in the region. However, the Europe market is estimated to grow at the highest CAGR during the forecast period owing to factors such as the Increasing prevalence of chronic diseases, Government support for drug development in Germany, Rising focus on biosimilar innovation in the UK, Favorable reimbursement scenario for various treatment options in France.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=100771004

Top Key Players: -

Prominent players in the wearable injectors market include Becton, Dickinson and Company(US), Ypsomed(Switzerland), Amgen(US), Subcuject(Denmark), Enable Injections, Inc(US), Medtronic Plc(Ireland), Insulet Corporation(US), United Therapeutics Corp (Us), CeQur SA(Switzerland), Sensile Medical(Switzerland).

Recent Developments:

• In April 2021, Medtronic launched the Infusion Set that can be worn up to seven days
• In April 2021, Amgen acquired Five Prime Therapeutics. This acquisition—for USD 38.00 per share in cash—was focused on developing immuno-oncology and targeted cancer therapies.
• In September 2020, Insulet Corporation expanded its presence in Sweden, Finland, Norway, and Denmark.

Conclusion:

The global wearable injectors market is expected to grow significantly during the forecast period. This is due to the increasing demand for wearable injectors, owing to their effectiveness and convenience in providing medication for chronic diseases. In addition, the development of new technologies such as self-injection systems and connected devices is propelling the growth of the market. Moreover, government initiatives aimed at the development of advanced healthcare infrastructure, the increasing prevalence of chronic diseases, and rising awareness about the benefits of wearable injectors are some of the major factors driving the growth of the market.

Revolutionizing Medical Imaging: The Growth of Digital X-ray Market

 As technology continues to advance, the medical field is seeing a significant transformation in the way diagnostics are performed. Digital X-ray is one of the key innovations that has transformed medical imaging and diagnosis.

The global digital X-ray market is expected to reach USD 16.4 billion by 2026 from an estimated USD 11.1 billion in 2021, at a CAGR of 8.1% from 2021 to 2026.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1164

KEY MARKET DYNAMICS

1.DRIVERS
                   1.1 Growing geriatric population and subsequent growth in disease incidence
                   1.2 Favorable government initiatives & investments
                   1.3 Advantages of digital X-ray systems over conventional analog systems
                   1.4 Continuous technological advancements and product development          

2.RESTRAINTS
                   2.1 High cost of digital X-ray systems
                   2.2 Regulatory changes in the US
                   2.3 Potential risks associated with radiation exposure

3. OPPORTUNITIES
                   3.1 Development of AI-based digital X-ray systems
                   3.2 Emerging markets in developing countries
                   3.3 Increasing adoption of teleradiology

4. CHALLENGES
                   4.1 Hospital budget cuts
                   4.2 Increasing adoption of refurbished systems
                   4.3 Dearth of trained professionals

Digital X-ray technology has numerous advantages over traditional X-ray methods. It provides a faster and more accurate diagnosis, requires less radiation exposure for patients, and enables easy storage and retrieval of images. Furthermore, it has allowed for the development of portable and wireless imaging devices that can be used in remote locations or emergency situations.

The growth of the digital X-ray market has been impressive, and it is expected to continue to grow at a significant rate in the coming years. The demand for these devices is being driven by factors such as the rising prevalence of chronic diseases, increasing investments in healthcare infrastructure, and the need for advanced imaging technologies to improve patient outcomes.

As this market continues to expand, it presents opportunities for key players in the healthcare industry to invest in research and development of new imaging technologies and software. By doing so, they can continue to improve the accuracy and efficiency of diagnostics and ultimately transform the future of medical care.

The digital X-ray market is indeed transforming the way medical diagnostics are performed. It is exciting to see the impact this technology is having on the healthcare industry and the possibilities it holds for the future.

Regional Analysis: -

The digital X-ray market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional market for digital X-ray systems, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Top Key Players: -

The digital X-ray market is dominated by Siemens Healthineers (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), and Canon, Inc. (Japan). The other leading market players include Carestream Health (US), Shimadzu Corporation (Japan), Hologic Inc. (US), Agfa-Gevaert Group (Belgium), Samsung Medison (South Korea), and Konica Minolta (Japan).

 

Urinary Catheter Market: Key Players, Market Segments, and Regional Analysis

 Introduction to the Urinary Catheters Market

Urinary catheters are medical devices used to drain urine from the bladder in cases of urinary retention, incontinence, and other conditions. They are also used to measure urine output in critically ill patients in hospitals. Growth in the market is attributed to the increasing geriatric population, rising prevalence of urinary disorders, technological advancements in urinary catheters, and increasing investments in healthcare infrastructure. Moreover, the increasing prevalence of urinary incontinence, rising awareness about urinary catheters, and growing demand for minimal invasive treatments are expected to drive the market growth.

Global Urinary Catheters Market Overview

The global Urinary catheters market size is projected to reach USD 2.6 billion by 2025, at a CAGR of 5.5%. The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of the urinary catheters market. However, the availability of alternative treatment options for urinary incontinence may restrict market growth to a certain extent.

The global urinary catheters market is anticipated to witness a healthy growth over the forecast period. The market is expected to be driven by increasing prevalence of urinary incontinence, rising geriatric population, and increasing awareness among people regarding the use of catheters. The market is further driven by the increasing prevalence of urinary tract infection (UTI) and rising number of individuals suffering from neurogenic bladder disorders.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132934629

 Drivers of the Urinary Catheters Market

·         The increasing prevalence of diseases such as urinary incontinence and urinary tract infections.

·         The rising demand for minimally invasive procedures.

·         The increasing availability and affordability of urinary catheters.

·         The growing geriatric population, which is more prone to developing urinary problems.

·         The increasing awareness of the benefits of using urinary catheters.

·         The technological advancements in the field of urinary catheters.

·         The increasing preference for home care settings.

·         The growing demand for disposable catheters.

·         The increasing government support for the healthcare sector.

·         The growing demand from emerging markets such as Asia Pacific and Latin America.

Opportunities of Urinary Catheters Market

·         Rising Demand for Urinary Catheters: The increasing prevalence of diseases that require the use of urinary catheters is expected to drive the urinary catheters market growth. The WHO estimates that the prevalence of urinary incontinence and other urinary problems, such as urinary tract infections, kidney stones, and bladder cancer, is increasing. This is expected to drive the demand for urinary catheters over the forecast period.

·         Growing Aging Population: The global aging population is expected to drive the growth of the urinary catheters market over the forecast period. An increasing number of people aged 65 and over is expected to lead to an increase in the prevalence of chronic diseases, such as urinary incontinence and urinary tract infections, and hence an increase in the demand for urinary catheters.

·         Technological Advancements: Technological advancements, such as the development of advanced urinary catheters, are expected to drive the growth of the urinary catheters market over the forecast period. Advanced catheters are designed to reduce the risk of infection, reduce trauma to the bladder, and provide comfort to the patient.

Regional Urinary Catheters Market Analysis

The urinary catheters market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. Factors such as the high prevalence of diseases, growing geriatric population, the availability of advanced interventional products (including urinary catheters), and increasing surgical procedures performed in the region are driving market growth in North America. 

Major Players in the Urinary Catheters Market

The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), and Cardinal Health (US).

Recent Developments in Urinary Catheters Market

• In 2019, Bactiguard launched BIP Foley TempSensor. This enhanced the urinary catheters product portfolio of Bactiguard.
• In 2019, ConvaTec Group acquired Southlake Medical Supplies, Inc. (US). This acquisition helped to strengthen ConvaTec’s distribution of catheter-related supplies in the US.
• In 2018, Coloplast acquired IncoCare Gunhild Vieler GmbH (Germany). This acquisition helped strengthen the company’s position in Germany, primarily in home care continence supplies.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=132934629

Conclusion:

The urinary catheters market is expected to grow at a healthy CAGR over the forecast period. The growth of the market is attributed to the increasing prevalence of urinary incontinence, and the increasing number of surgeries and diagnostic procedures. The increasing geriatric population is also expected to boost the growth of the market. The increasing emphasis on minimally invasive procedures, and the emergence of technologically advanced catheters are anticipated to drive the market growth. The rising awareness and acceptance of catheters among patients, along with the availability of reimbursement for catheters in some countries, are expected to fuel the growth of the market. However, the fear of infection associated with the use of catheters, and the rising preference for alternative treatments such as electrical nerve stimulation are anticipated to hamper the growth of the market. The increasing investments in research and development activities, and the growing focus on developing innovative catheter technologies are expected to provide lucrative opportunities for the market players.